Challenge: PP Filament with Antibacterial Activity Ready for Orthopedic 3D Printing Application - Technology Org | By The Digital Insider
NineSigma, representing Enky-3DP, is seeking organizations, who are currently operating in the field of Medical Devices that would like to collaborate to develop new orthopedic and prostethic products using ENKY´s Antibacterial 3D Filaments.

Doctors during a surgery – illustrative photo. Image credit: Olga Guryanova via Unsplash, free license
ENKY-3DP develops, produces and sells thermoplastics filaments for 3D printing applications while bringing expertise in specific formulations development, and selection of technical, reliable material sources, production through extrusion of filaments with constant and agreed specifications. ENKY 3D filaments offer diversity and capacity to create on-demand formulations allows them to meet requirements of a large pattern of applications and market segments.
ENKY-3DP engineer & technician team is also formulating & producing all thermoplastics to achieve specific properties and add new functional properties to filaments while providing technical support to analyze the products or to scale-up client process.
With this project, ENKY-3DP is welcoming partnership interests from organizations who believe they can benefit from ENKY PP & PA11 Filament with Anti-bacterial activity that are spesifically developed to be used in orthopedic and prosthetic applications.
Submissions to this Challenge must be received by Dec 15, 2023.
Source: NineSights
#2023, #3D, #3DPrinting, #Amp, #Applications, #Challenge, #ChemistryMaterialsScienceNews, #Collaborate, #Competitions, #Development, #Devices, #Diversity, #Engineer, #FeaturedTechnologyNews, #Link, #Material, #MedicalDevices, #Organizations, #Orthopedics, #Photo, #Printing, #Process, #Production, #Project, #Scale, #Surgery, #Technology
Published on The Digital Insider at https://thedigitalinsider.com/challenge-pp-filament-with-antibacterial-activity-ready-for-orthopedic-3d-printing-application-technology-org/.
Comments
Post a Comment
Comments are moderated.